Company Search:
Advanced Search
Sponsored Links
Keryx Biopharmaceuticals, Inc. Company Snapshot
Keryx Biopharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Keryx Biopharmaceuticals with three other companies in this sector in the United States: Cumberland Pharmaceuticals Incorporation (2016 sales of $33.03 million of which 100% was Specialty Pharmaceutical Products), Aoxing Pharmaceutical Company Inc ($32.33 million ), and Corium International Inc ($33.02 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Keryx Biopharmaceuticals, Inc.
  Stock Performance Chart for Keryx Biopharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (9/22/2017): 6.95
(Figures in U.S. Dollars)
1 Week -3.3%   13 Weeks -0.3%  
4 Weeks 3.0%   52 Weeks 32.4%  
Keryx Biopharmaceuticals, Inc. Key Data:
  Ticker: KERX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 31,983,000
(Year Ending Jan 2017).
Employees: 193
  Currency: U.S. Dollars Market Cap: 825,314,105
  Fiscal Yr Ends: December Shares Outstanding: 118,750,231
  Share Type: Common Closely Held Shares: 1,573,554
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.